Anemia | The Safety and Effectiveness of Jobelyn in Pre-operative Management of Anaemia in Gynaecological Patients
Anemia research study
What is the primary objective of this study?
PROTOCOL FOR THE STUDY OF THE SAFETY AND EFFICACY OF JOBELYN, IN THE PREOPERATIVE MANAGEMENT OF ANAEMIA IN GYNAECOLOGICAL PATIENTS
Who is eligible to participate?
Inclusion Criteria: - Mild to moderate anaemia - Asymptomatic severe anaemia - Non life threatening gynaecological condition Exclusion Criteria: - Failure to give informed consent - Symptomatic severe anaemia - Pregnancy - Malignancies and Chronic inflammatory disease
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Dietary Supplement:JobelynJobelyn is a sorghum bicolor extract marketed as dietary supplement
Drug:Ferrous Sulphate + Folic AcidFerrous Sulphate 600mg, thrice daily + Folic Acid, 5mg daily
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Jobelyn + Ferrous Sulphate + Folic AcidCaps Jobelyn 250mg, 12 hourly + Ferrous Sulphate 600mg thrice daily + Folic Acid 5mg daily
Ferrous Sulphate + Folic AcidFerrous Sulphate 600mg, thrice daily + Folic Acid, 5mg daily
Start Date: December 2012
Completed Date: December 2013
Phase: Phase 2
Primary Outcome: Anaemia
Secondary Outcome: morbidity
Study sponsors, principal investigator, and references
Principal Investigator: Adetokunbo O Tayo, M.D.
Lead Sponsor: Lagos State University
Collaborator: Health Forever Product Limited. Lagos, Nigeria
Bröhan M, Jerkovic V, Collin S. Potentiality of red sorghum for producing stilbenoid-enriched beers with high antioxidant activity. J Agric Food Chem. 2011 Apr 27;59(8):4088-94. doi: 10.1021/jf1047755. Epub 2011 Mar 7.